Differences in the serum nonesterified fatty acid profile of young women associated with a recent history of gestational diabetes and overweight/obesity

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Fugmann, Marina ^a,b,c   Uhl, Olaf ^a   Hellmuth, Christian ^a   Hetterich, Holger ^a   Kammer, Nora N ^a   Ferrari, Uta ^a,b,c   Parhofer, Klaus G ^a   Koletzko, Berthold ^a   Seissler, Jochen ^a,b,c   Lechner, Andreas ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; FATTY ACID; FETUIN A; HEMOGLOBIN A1C; LEPTIN; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; RESISTIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MEDICAL HISTORY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; QUESTIONNAIRE; BLOOD; DIAGNOSTIC IMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; RADIOGRAPHY;

ADULT; BIOMARKERS; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FATTY ACIDS; FEMALE; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; OBESITY; PREGNANCY; RADIOGRAPHY;

EID: 84930216501     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128001     Document Type: Article

References (43)

1. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002; 51(1):7-18. PMID: 11756317.
2. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes. 2003; 52(10):2461-74. PMID: 14514628.
3. Roden M. Does endurance training protect from lipotoxicity? Diabetes. 2012; 61(10):2397-9. Epub 2012/09/22. doi: 10.2337/db12-0662 PMID: 22997429; PubMed Central PMCID: PMC3447918.
4. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature reviews Molecular cell biology. 2008; 9(5):367-77. Epub 2008/04/11. doi: 10.1038/nrm2391 PMID: 18401346; PubMed Central PMCID: PMC2886982.
5. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006; 444(7121):840-6. Epub 2006/12/15. doi: 10.1038/nature05482 PMID: 17167471.
6. Il'yasova D, Wang F, D'Agostino RB Jr., Hanley A, Wagenknecht LE. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia. 2010; 53(5):866-74. Epub 2010/02/10. doi: 10.1007/s00125-010-1657-4 PMID: 20143044; PubMed Central PMCID: PMC3660100.
7. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, et al. Mechanism of free fatty acid-induced insulin resistance in humans. The Journal of clinical investigation. 1996; 97(12):2859-65. doi: 10.1172/JCI118742 PMID: 8675698; PubMed Central PMCID: PMC507380.
8. Hara T, Kimura I, Inoue D, Ichimura A, Hirasawa A. Free fatty acid receptors and their role in regulation of energy metabolism. Reviews of physiology, biochemistry and pharmacology. 2013; 164:77-116. Epub 2013/04/30. doi: 10.1007/112-2013-13 PMID: 23625068.
9. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. The Journal of clinical investigation. 2006; 116(11):3015-25. Epub 2006/10/21. doi: 10.1172/JCI28898 PMID: 17053832; PubMed Central PMCID: PMC1616196.
10. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell. 2010; 142(5):687-98. Epub 2010/09/04. doi: 10.1016/j.cell.2010.07.041 PMID: 20813258; PubMed Central PMCID: PMC2956412.
11. Grapov D, Adams SH, Pedersen TL, Garvey WT, Newman JW. Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PloS one. 2012; 7(11):e48852. Epub 2012/11/13. doi: 10.1371/journal.pone.0048852 PMID: 23144998; PubMed Central PMCID: PMC3493609.
12. Novgorodtseva TP, Karaman YK, Zhukova NV, Lobanova EG, Antonyuk MV, Kantur TA. Composition of fatty acids in plasma and erythrocytes and eicosanoids level in patients with metabolic syndrome. Lipids in health and disease. 2011; 10:82. Epub 2011/05/21. doi: 10.1186/1476-511X-10-82 PMID: 21595891; PubMed Central PMCID: PMC3116500.
13. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. The Journal of clinical endocrinology and metabolism. 2002; 87(7):3227-35. Epub 2002/07/11. doi: 10.1210/jcem.87.7.8684 PMID: 12107230.
14. Feig DS, Zinman B, Wang X, Hux JE. Risk of development of diabetes mellitus after diagnosis of gestational diabetes. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. 2008; 179(3):229-34. doi: 10.1503/cmaj.080012 PMID: 18663202; PubMed Central PMCID: PMC2474881.
15. Rottenkolber M, Ferrari U, Holland L, Aertsen S, Kammer NN, Hetterich H, et al. The diabetes risk phenotype of young women with recent gestational diabetes. The Journal of clinical endocrinology and metabolism. 2015:jc20143898. doi: 10.1210/jc.2014-3898 PMID: 25742512.
16. IADPSG, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010; 33(3):676-82. doi: 10.2337/dc09-1848 PMID: 20190296; PubMed Central PMCID: PMC2827530.
17. Kroke A, Klipstein-Grobusch K, Voss S, Moseneder J, Thielecke F, Noack R, et al. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) Study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. The American journal of clinical nutrition. 1999; 70(4):439-47. Epub 1999/09/29. PMID: 10500011.
18. Hu HH, Nayak KS, Goran MI. Assessment of abdominal adipose tissue and organ fat content by magnetic resonance imaging. Obesity reviews: an official journal of the International Association for the Study of Obesity. 2011; 12(5):e504-15. Epub 2011/02/26. doi: 10.1111/j.1467-789X.2010.00824.x PMID: 21348916; PubMed Central PMCID: PMC3079791.
19. Reeder SB, Cruite I, Hamilton G, Sirlin CB. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. Journal of magnetic resonance imaging: JMRI. 2011; 34(4):spcone. Epub 2011/10/26. doi: 10.1002/jmri.22775 PMID: 22025886; PubMed Central PMCID: PMC3177109.
20. Hellmuth C, Weber M, Koletzko B, Peissner W. Nonesterified fatty acid determination for functional lipidomics: comprehensive ultrahigh performance liquid chromatography-tandem mass spectrometry quantitation, qualification, and parameter prediction. Analytical chemistry. 2012; 84(3):1483-90. Epub 2012/01/10. doi: 10.1021/ac202602u PMID: 22224852.
21. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Progress in lipid research. 2008; 47(5):348-80. Epub 2008/04/26. doi: 10.1016/j.plipres.2008.03.003 PMID: 18435934.
22. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes care. 1999; 22(9):1462-70. Epub 1999/09/10. PMID: 10480510.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. Epub 1985/07/01. PMID: 3899825.
24. Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, Defronzo RA. Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta diabetologica. 2008; 45(3):147-50. Epub 2008/03/22. doi: 10.1007/s00592-008-0033-z PMID: 18357404.
25. Lorenzo C, Wagenknecht LE, Rewers MJ, Karter AJ, Bergman RN, Hanley AJ, et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes care. 2010; 33(9):2098-103. doi: 10.2337/dc10-0165 PMID: 20805282; PubMed Central PMCID: PMC2928371.
26. Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes. 2011; 60(10):2441-9. doi: 10.2337/db11-0425 PMID: 21948998; PubMed Central PMCID: PMC3178283.
27. Koutsari C, Dumesic DA, Patterson BW, Votruba SB, Jensen MD. Plasma free fatty acid storage in subcutaneous and visceral adipose tissue in postabsorptive women. Diabetes. 2008; 57(5):1186-94. doi: 10.2337/db07-0664 PMID: 18285557.
28. Hellmuth C, Demmelmair H, Schmitt I, Peissner W, Bluher M, Koletzko B. Association between plasma nonesterified fatty acids species and adipose tissue fatty acid composition. PloS one. 2013; 8(10):e74927. doi: 10.1371/journal.pone.0074927 PMID: 24098359; PubMed Central PMCID: PMC3788793.
29. Baylin A, Kabagambe EK, Siles X, Campos H. Adipose tissue biomarkers of fatty acid intake. The American journal of clinical nutrition. 2002; 76(4):750-7. Epub 2002/09/27. PMID: 12324287.
30. Vessby B, Gustafsson IB, Tengblad S, Boberg M, Andersson A. Desaturation and elongation of Fatty acids and insulin action. Annals of the New York Academy of Sciences. 2002; 967:183-95. Epub 2002/06/25. PMID: 12079847.
31. Matsuzaka T, Shimano H. Elovl6: a new player in fatty acid metabolism and insulin sensitivity. J Mol Med (Berl). 2009; 87(4):379-84. Epub 2009/03/05. doi: 10.1007/s00109-009-0449-0 PMID: 19259639.
32. Liu X, Strable MS, Ntambi JM. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv Nutr. 2011; 2(1):15-22. Epub 2012/01/03. doi: 10.3945/an.110.000125 PMID: 22211186; PubMed Central PMCID: PMC3042787.
33. Fessler MB, Rudel LL, Brown JM. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Current opinion in lipidology. 2009; 20(5):379-85. doi: 10.1097/MOL.0b013e32832fa5c4 PMID: 19625959; PubMed Central PMCID: PMC3099529.
34. Sjogren P, Sierra-Johnson J, Gertow K, Rosell M, Vessby B, de Faire U, et al. Fatty acid desaturases in human adipose tissue: relationships between gene expression, desaturation indexes and insulin resistance. Diabetologia. 2008; 51(2):328-35. Epub 2007/11/22. doi: 10.1007/s00125-007-0876-9 PMID: 18030445.
35. Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S. Diabetes. 2013; 62(1):49-55. Epub 2012/08/28. doi: 10.2337/db12-0372 PMID: 22923470; PubMed Central PMCID: PMC3526056.
36. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes. 2008; 57(10):2762-7. Epub 2008/07/18. doi: 10.2337/db08-0538 PMID: 18633113; PubMed Central PMCID: PMC2551687.
37. Heinrichsdorff J, Olefsky JM. Fetuin-A: the missing link in lipid-induced inflammation. Nature medicine. 2012; 18(8):1182-3. Epub 2012/08/08. doi: 10.1038/nm.2869 PMID: 22869185.
38. Calder PC. Fatty acids and inflammation: the cutting edge between food and pharma. European journal of pharmacology. 2011; 668 Suppl 1:S50-8. doi: 10.1016/j.ejphar.2011.05.085 PMID: 21816146.
39. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnology journal. 2006; 1(4):420-39. doi: 10.1002/biot.200600012 PMID: 16892270.
40. Patterson E, Wall R, Fitzgerald GF, Ross RP, Stanton C. Health implications of high dietary omega-6 polyunsaturated Fatty acids. Journal of nutrition and metabolism. 2012; 2012:539426. doi: 10.1155/2012/539426 PMID: 22570770; PubMed Central PMCID: PMC3335257.
41. Iggman D, Arnlov J, Vessby B, Cederholm T, Sjogren P, Riserus U. Adipose tissue fatty acids and insulin sensitivity in elderly men. Diabetologia. 2010; 53(5):850-7. doi: 10.1007/s00125-010-1669-0 PMID: 20127308.
42. Bays HE, Gonzalez-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert review of cardiovascular therapy. 2008; 6(3):343-68. doi: 10.1586/14779072.6.3.343 PMID: 18327995.
43. Menni C, Fauman E, Erte I, Perry JR, Kastenmuller G, Shin SY, et al. Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes. 2013; 62(12):4270-6. doi: 10.2337/db13-0570 PMID: 23884885; PubMed Central PMCID: PMC3837024.